All information you are about to see is related to a specific selected market, including the products’ portfolio, and therefore comply to different local regulations.

Our financial data in facts & figures

OUR REVENUES

EBITDA (2025)

110,1 (20,5% of turnover)

EBIT (2025)

60.1

NET RESULT (2025)

33.9

OUR FIGURES BY FOCUS AREA (%, 2025)

30 %

JOINT CARE

19 %

EYE CARE

18 %

SPECIALTY CARE

8 %

SKIN CARE

9 %

HEALTH & WELLNESS CARE

16 %

OTHER

OUR FIGURES BY PRODUCT CATEGORY (2025)

45 %

PRESCRIPTION DRUGS

36 %

MEDICAL DEVICES

4 %

VACCINES

14 %

OTHER

OUR FIGURES BY GEOGRAPHICAL AREA (%, 2025)

45,6 %

ITALY

28,8 %

EUROPE

5,3 %

USA

12,8 %

MENA

7,5 %

RoW

OUR GROUP

GOVERNANCE

Find out more